Prospective, randomized, parallel-group trial to evaluate the effects of lactulose and polyethylene glycol-4000 on colonic flora in chronic idiopathic constipation

Alimentary Pharmacology and Therapeutics

Volumn 19, Issue 8, 2004, Pages 889-899

  Bouhnik, Y ^a   Neut, C ^b   Raskine, L ^a   Michel, C ^c   Riottot, M ^d   Andrieux, C ^c   Guillemot, F ^e   Dyard, F ^f   Flourie B ^g  

^a HÔPITAL LARIBOISIÈRE   (France)

^b UNIV LILLE   (France)

^c CEMAGREF   (France)

^d Bernard Maton Lab Physiol M   (France)

^e LILLE UNIVERSITY HOSPITAL   (France)

^f Laboratoires Solvay Pharma   (France)

^g CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; BETA GALACTOSIDASE; BILE ACID; BUTYRIC ACID; LACTULOSE; MACROGOL 4000; SHORT CHAIN FATTY ACID; STEROL;

ADULT; AGED; ARTICLE; BACTERIAL COUNT; BACTEROIDES; BIFIDOBACTERIUM; CHRONIC DISEASE; CHRONIC IDIOPATHIC CONSTIPATION; CLINICAL TRIAL; CLOSTRIDIUM; COLON FLORA; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; ENTEROBACTERIACEAE; ENZYME ACTIVITY; FECES ANALYSIS; FECES MICROFLORA; FEMALE; HUMAN; IDIOPATHIC DISEASE; LACTOBACILLUS; MAJOR CLINICAL STUDY; MALE; METABOLISM; MULTICENTER STUDY; PARALLEL DESIGN; PH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL;

EID: 2042511019     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2004.01918.x     Document Type: Article

References (46)

1. Badiali D, Corazziari E, Habib FI, et al. Effect of wheat bran in treatment of chronic nonorganic constipation. A double-blind controlled trial. Dig Dis Sci 1995; 40: 349-56.
2. Graham DY, Moser SE, Estes MK. The effect of bran on bowel function in constipation. Am J Gastroenterol 1982; 77: 599-603.
3. Francis CY, Whorwell PJ. Bran and irritable bowel syndrome: time of reappraisal. Lancet 1994; 344: 39-40.
4. Schiller LR. Review article: the therapy of constipation. Aliment Pharmacol Ther 2001; 15: 749-63.
5. Thompson WG. Laxatives: clinical pharmacology and practical use. Drugs 1980; 19: 49-58.
6. Clausen MR, Mortensen PB. Lactulose, disaccharides and colonic flora. Clinical consequences. Drugs 1997; 53: 930-42.
7. Sanders JF. Lactulose syrup assessed in a double-blind study of elderly constipated patients. J Am Geriatr Soc 1978; 26: 236-9.
8. Lederle FA, Busch DL, Mattox KM, et al. Cost-effective treatment of constipation in the elderly: a randomized double-blind comparison of sorbitol and lactulose. Am J Med 1990; 89: 597-601.
9. Passmore AP, Wilson-Davies K, Stoker C, et al. Chronic constipation in long-stay elderly patients: a comparison of lactulose and a senna-fibre combination. Br Med J 1993; 307: 769-71.
10. Ballongue J, Schumann C, Quignon P. Effects of lactulose and lactitol on colonic microflora and enzymatic activity. Scand J Gastroenterol 1997; 32: 41-4.
11. Bouhnik Y, Riottot M, Telotte A, et al. Lactulose ingestion increases fecal bifidobacterial counts. A randomized double blind study in healthy humans. Eur J Clin Nutr 2004; 58: 462-6.
12. Nagengast FM, Hectors MP, Buys WA, et al. Inhibition of secondary bile acid formation in the large intestine by lactulose in healthy subjects of two different age groups. Eur J Clin Invest 1988; 18: 56-61.
13. Florent C, Flourié B, Leblond A, et al. Influence of chronic lactulose ingestion on the colonic metabolism of lactulose in man (an in vivo study). J Clin Invest 1985; 75: 608-13.
14. Evans DF, Pye G, Bramley R, et al. Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut 1988; 29: 1035-41.
15. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 1995; 125: 1401-12.
16. Andorsky RI, Goldner F. Colonic lavage solution (polyethylene glycol electrolyte lavage solution) as a treatment for chronic constipation: a double-blind, placebo-controlled study. Am J Gastroenterol 1990; 85: 261-5.
17. DiPalma JA, DeRidder PH, Orlando RC, et al. Randomized, placebo-controlled, multicenter study of the safety and efficacy of a new polyethylene glycol laxative. Am J Gastroenterol 2000; 95: 446-50.
18. Drossman DA, ed. The Functional Gastrointestinal Disorders. Boston: Little, Brown, 1994: 115-73.
19. Bouhnik Y, Pochart P, Marteau P, et al. Fecal recovery in humans of viable Bifidobacterium sp ingested in fermented milk. Gastroenterology 1992; 102: 875-8.
20. Stephen AM, Cummings JH. The microbial contribution to human faecal mass. J Med Microbiol 1980; 13: 45-56.
21. Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with Folin phenol reagent. J Biol Chem 1951; 193: 265-75.
22. Riottot M, Olivier P, Huet A, et al. Hypolipidemic effects of beta-cyclodextrin in the hamster and in the genetically hypercholesterolemic Rico rat. Lipids 1993; 28: 181-8.
23. Stempfel RS, Sidbury JB. Studies with the hydroxysteroid deshydrogenase. A simplified method for the enzymatic estimation of 3 and 17 hydroxysteroids. J Clin Endocrinol 1964; 24: 367-72.
24. Zijlstra JB, Beukema J, Wolthers BG, et al. Pretreatment methods prior to chromatographic analysis of volatile fatty acids from faecal samples. Clin Chim Acta 1977; 78; 243-50.
25. Guerrant GO, Lambert MA, Moss CW. Analysis of short chain fatty acids from anaerobic bacteria by high performance liquid chromatography. J Clin Microbiol 1982; 16: 355-60.
26. Stein J, Kulemeier B, Lembcke B, et al. Simple and rapid method for determination of short-chain fatty acids in biological materials by high-performance liquid chromatography with ultraviolet detection. J Chromatogr 1992; 576: 53-61.
27. Sobhani I, Sansarricq M, Flourie B. [Laxative effect and tolerance of lactulose administered in one or two intakes in the treatment of chronic idiopathic constipation. Groupe d'Investigateurs d'Ile-de-France (GIIF)]. Gastroenterol Clin Biol 1996; 20: 362-6.
28. Attar A, Lemann M, Ferguson A, et al. Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation. Gut 1999; 44: 226-30.
29. Conn HO, Floch MH. Effects of lactulose and Lactobacillus acidophilus on the fecal flora. Am J Clin Nutr 1970; 23: 1588-94.
30. Terada A, Hara H, Kataoka M, et al. Effect of lactulose on composition and metabolic activity of the human fecal flora. Microb Ecol Health Dis 1992; 5: 43-50.
31. Mitsuoka T. Intestinal flora and aging. Nutr Rev 1992; 50: 438-46.
32. Kleessen B, Sykura B, Zunft HJ, et al. Effects of inulin and lactose on fecal microflora, microbial activity, and bowel habit in elderly constipated persons. Am J Clin Nutr 1997; 65: 1397-402.
33. Ouwehand AC, Isolauri E, Kirjavainen PV, et al. Adhesion of four Bifidobacterium strains to human intestinal mucus from subjects in different age groups. FEMS Microbiol Lett 1999; 172: 61-4.
34. Roy D, Berger JL, Reuter G. Characterization of dairy-related Bifidobacterium spp. based on their beta-galactosidase electrophoretic patterns. Int J Food Microbiol 1994; 23: 55-70.
35. Favier C, Neut C, Mizon C, et al. Fecal β-D-galactosidase production and bifidobacteria are decreased in Crohn's disease. Dig Dis Sci 1997; 42: 817-22.
36. Hammer HF, Santa Ana CA, Schiller LR, et al. Studies of osmotic diarrhea induced in normal subjects by ingestion of polyethylene glycol and lactulose. J Clin Invest 1989; 84: 1056-62.
37. Malhotra SL. Faecal urobilinogen levels and pH of stools in population groups with different incidence of cancer of the colon, and their possible role in its aetiology. J R Soc Med 1982; 75: 709-14.
38. Samelson SL, Nelson RL, Nyhus LM. Protective role of faecal pH in experimental colon carcinogenesis. J R Soc Med 1985; 78: 230-3.
39. Pryde SE, Duncan SH, Hold GL, et al. The microbiology of butyrate formation in the human colon. FEMS Microbiol Lett 2002; 217: 133-9.
40. Reddy BS, Watanabe K, Weisburger JH, et al. Promoting effect of bile acids in colon carcinogenesis in germ free and conventional F344 rats. Cancer Res 1977; 37: 3238-42.
41. Gorbach SL, Goldin BR. The intestinal microflora and the colon cancer connection. Rev Infect Dis 1990; 12: S252-61.
42. Hori T, Matsumoto K, Sakaitani Y, et al. Effect of dietary deoxycholic acid and cholesterol on fecal steroid concentration and its impact on the colonic crypt cell proliferation in azoxymethane-treated rats. Cancer Lett 1998; 124: 79-84.
43. Nair PP. Role of bile acids and neutral sterols in carcinogenesis. Am J Clin Nutr 1988; 48: 768-74.
44. Owen RW. Faecal steroids and colorectal carcinogenesis. Scand J Gastroenterol 1997; 222: 76-82.
45. Nagengast FM, Grubben MJ, van Munster IP. Role of bile acids in colorectal carcinogenesis. Eur J Cancer 1995; 31A: 1067-70.
46. Finegold SM, Sutter VL, Mathisen GE. Normal indigenous intestinal flora. In: Hentges DJ, ed. Human Intestinal Microflora in Health and Disease, New York: Academic Press. 1983: 3-31.